Close Menu

aneuploidy

The firm said in an SEC document that it plans to offer 6.25 million shares and expects net proceeds of up to $103.3 million.

The UK NIPT firm said that is creating a provision of £500,000 to cover expected expenses related to litigation involving Illumina.

The partners will leverage IME's rare cell isolation technology, a microchip containing a microfabricated filter membrane to isolate and enrich fetal cells from maternal blood.

Patent law experts said the ruling provides further clarity over what is and is not patentable within the broader molecular diagnostics field. 

The results were presented at the ESHG meeting in Scotland this weekend and could potentially influence how NIPT is offered in those countries.

With evidence of significant variation among consent procedures in the NIPT space, and the potential for a lack of awareness about incidental findings, Bianchi recommends the field come together to standardize procedures and education.

In addition to offering NIPTs, Natera is eyeing the cancer diagnostics space.

The UK firm is using MALDI-TOF mass spec technology to develop the test as a screening tool for the disorder as early as eight weeks into a pregnancy.

Natera Raises $55.5M

The company said that the financing will go toward sales and marketing, as well as R&D on its Panorama NIPT, diagnostic tests for cancer, and clinical trials. 

Three new studies, published online in the New England Journal of Medicine, shed light on how NIPT may be best integrated into clinical care for all pregnant women.

Pages

The American Prospect writes that the pilot program to test the DNA of migrants could lead to more family separations.

An international commission is to develop a report on how researchers, clinicians, and regulators should evaluate the clinical applications of human germline genome editing.

The US Department of Agriculture presents a new blueprint for animal genomic research.

In Genome Research this week: repetitive element deletion linked to altered methylation and more in form of muscular dystrophy; human contamination in draft bacterial and archaeal genomes; and more.